What will shape the Pharma landscape in Q3 2025?
Upcoming drug approvals and clinical progress will be pivotal during the third quarter of the year, says GlobalData.
List view / Grid view
Upcoming drug approvals and clinical progress will be pivotal during the third quarter of the year, says GlobalData.
30 July 2015 | By Victoria White
Ascendis Pharma has announced positive top-line results from a study evaluating the safety and efficacy of TransCon Growth Hormone in children with GHD...